Can spironolactone affect menstrual cycles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Spironolactone's Effect on Menstrual Cycles

Yes, spironolactone commonly causes menstrual irregularities in 15-30% of women, with this side effect being dose-dependent and one of the most frequently reported adverse effects of the medication. 1, 2

Mechanism and Frequency of Menstrual Changes

Spironolactone affects menstrual cycles through its anti-androgenic properties and hormonal effects:

  • It works by decreasing testosterone production, inhibiting androgen receptors, and affecting hormone binding globulin 2
  • Menstrual irregularities are the most common side effect, occurring in 15-30% of women taking the medication 2
  • The risk increases significantly with higher doses, with a relative risk of 4.12 for women taking 200mg/day compared to lower doses 1
  • Common menstrual changes include:
    • Metrorrhagia (irregular bleeding)
    • Shortened menstrual cycles (as short as 14-day cycles in some cases) 3
    • Polymenorrhea (frequent menstrual periods) 4

Dose-Related Effects

The likelihood of experiencing menstrual irregularities correlates strongly with the dosage:

  • At 100mg twice daily (200mg total): Up to 68% of women may experience side effects severe enough to require dose reduction or discontinuation 3
  • At 50mg twice daily (100mg total): Significantly fewer side effects, with only about 20% experiencing menstrual irregularities 3
  • The American Academy of Dermatology recommends starting at 50mg daily and increasing as needed, which helps minimize these side effects 2

Management of Menstrual Side Effects

To address menstrual irregularities while continuing spironolactone therapy:

  • Concomitant use of combined oral contraceptives (COCs) is highly effective in regulating menstrual cycles while on spironolactone 2
  • Hormonal intrauterine devices can also help minimize menstrual irregularities 1
  • Cyclical administration (days 4-21 of the menstrual cycle) rather than continuous dosing may reduce the incidence of irregular bleeding 3
  • Starting at a lower dose (50mg daily) and gradually increasing as needed and tolerated can minimize side effects 2

Timing and Duration of Effects

  • Menstrual irregularities typically occur early in treatment 5
  • Regular monitoring during the first 3 months of treatment is advised to assess for side effects 5
  • These effects are generally not dangerous but can be bothersome enough that some women discontinue treatment 3

Other Common Side Effects

While menstrual irregularities are most common, other side effects include:

  • Diuresis (29%)
  • Breast tenderness (3-5%)
  • Breast enlargement
  • Dizziness (3-4%)
  • Nausea (2-4%)
  • Polyuria (1-2%)
  • Fatigue (1-2%)
  • Headache (2%) 1, 2

Important Considerations

  • Spironolactone is pregnancy category C and should not be used during pregnancy due to potential feminization of male fetuses 1, 2
  • Despite menstrual irregularities, spironolactone does not appear to act as a progestin or antiprogestin on the human endometrium 6
  • The menstrual effects are reversible upon discontinuation of the medication
  • In studies examining long-term use, no serious adverse effects were noted with treatment durations up to 8 years 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acne and Hormonal Disorder Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Side-effects of spironolactone therapy in the hirsute woman.

The Journal of clinical endocrinology and metabolism, 1988

Research

Low dose spironolactone in the treatment of female hyperandrogenemia and hirsutism.

Acta Universitatis Palackianae Olomucensis Facultatis Medicae, 1993

Research

Tolerance of spironolactone.

The British journal of dermatology, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.